Camex (524440)
CyclicalScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹59.61 |
| Market Cap | ₹62.08 Cr |
| P/E Ratio | 20.77 |
| ROCE | 9.07% |
| ROE | 3.68% |
| Dividend Yield | 0% |
| Profit Growth | 415.38% |
| Debt/Equity | — |
| Sales Growth | 29.81% |
| 52-Week Range | ₹26.37 — ₹59.61 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹46.21 |
Strengths
- Sales growth of 29.81% shows healthy top-line momentum.
- Piotroski F-score of 7/9 suggests recent fundamental improvements.
- P/B of 1.29 against book value of ₹46.21 offers some asset support.
- Latest quarter revenue of ₹37 crore indicates a reasonable operating scale for a ₹62 crore market cap.
Concerns
- ROE of 3.68% and ROCE of 9.07% are weak for a commodity chemicals business.
- Latest quarter net profit of ₹1 crore on ₹37 crore sales implies a thin 2.7% margin.
- P/E of 20.77 looks expensive given low profitability and a 415% profit growth inflated by a low base.
- Dividend yield is zero, and promoter holding plus debt-equity data are unavailable, limiting transparency.
AI Analysis
Camex is the kind of small-cap commodity chemical stock that makes me reach for my wallet slowly. At ₹59.61, the market cap is ₹62 crore and book value is ₹46.21, so the stock trades at 1.29 times book. On assets, it is not outrageously expensive. But the first test of a good business is return on capital, and here ROE is just 3.68% while ROCE is 9.07%. That is not a wonderful compounding machine. The latest quarter shows ₹37 crore sales but only ₹1 crore net profit—a thin 2.7% margin. Profit growth of 415% sounds extraordinary, but it is coming from a tiny base, and in commodity chemicals such swings are often cyclical, not durable. Sales growth of 29.81% is encouraging, yet without pricing power or a moat, growth can eat capital when the cycle turns. The Piotroski F-score of 7/9 suggests improving fundamentals, and the PEG ratio of 0.09 seems seductively cheap, but that ratio is only meaningful if the recent profit growth is sustainable—which I doubt. There is zero dividend yield, so investors rely entirely on price appreciation. We have no promoter holding or debt-equity data, which itself is a red flag for transparency. Graham would demand a margin of safety; at 20.77 times earnings and 1.29 times book, with low returns on equity, I do not see one. This is a watch-list cyclical, not a business I would own at the current price.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer